Effect of dutasteride on the risk of prostate cancer.

The effect of dutasteride on microscopic and macroscopic changes of testosterone replacement treatment on prostate tissue

Diri, Mehmet Akif
Diri, Banu
Yıldız, Levent
Büyükalpelli, Recep

January 2018

WOS: 000451785300010PubMed: 30024036Testosterone replacement therapy has a growing interest in daily...

Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study

Schroeder, Fritz H.
Bangma, Chris H.
Wolff, Johannes M.
Alcaraz, Antonio
Montorsi, Francesco
Mongiat-Artus, Pierre
Abrahamsson, Per-Anders
McNicholas, Tom A.
Castro, Ramiro S.
Nandy, Indrani M.

January 2009

To describe the Avodart after Radical Therapy for prostate cancer Study (ARTS), investigating the us...

Steroid Hormone Receptors As Potential Mediators Of The Clinical Effects Of Dutasteride: A Prospective, Randomized, Double-blind Study

Alonso
Joao C. C.
Leonardo O.
Patrick V.
Ubirajara
Wagner E.
Fabiano A.
Ronald F.
Maria Isabel C.
Wagner J.

November 2017

This study characterizes the clinical and morphofunctional effects of a 5 alpha-reductase inhibitor ...

Effect of dutasteride on the risk of prostate cancer.

Andriole, G.L.
Bostwick, D.G.
Brawley, O.W.
Gomella, L.G.
Marberger, M.
Montorsi, F.
Pettaway, C.A.
Tammela, T.L.J.
Teloken, C.
Tindall, D.J.
Somerville, M.C.
Wilson, T.H.
Fowler, I.L.
Rittmaster, R.S.
Mulders, P.F.A.
Schrier, B.P.
et al.

January 2010

BACKGROUND: We conducted a study to determine whether dutasteride reduces the risk of incident prost...

Effect of Dutasteride on the Risk of Prostate Cancer

Donald J. Tindall
Ivy L. Fowler
Roger S. Rittmaster
N Engl
J Med

December 2014

*The principal investigators in the Reduc-tion by Dutasteride of Prostate Cancer Events (REDUCE) stu...

The effect of dutasteride on magnetic resonance imaging defined prostate cancer: MAPPED-a randomized, placebo controlled, double-blind clinical trial

Moore, CM
Robertson, NL
Jichi, F
Damola, A
Ambler, G
Giganti, F
Ridout, AJ
Bott, SRJ
Winkler, M
Ahmed, HU
Arya, M
Mitra, AV
McCartan, N
Freeman, A
Jameson, C
Castro, R
Gambarota, G
Whitcher, BJ
Allen, C
Kirkham, A
Emberton, M

November 2016

Purpose Dutasteride, which is licensed for symptomatic benign prostatic hyperplasia, has been associ...

The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical Trial

Moore, Caroline M.
Robertson, Nicola L.
Jichi, Fatima
Damola, Adebiyi
Ambler, Gareth
Giganti, Francesco
Ridout, Ashley J.
Bott, Simon R. J.
Winkler, Mathias
Ahmed, Hashim U.
Arya, Manit
Mitra, Anita V.
McCartan, Neil
Freeman, Alex
Jameson, Charles
Castro, Ramiro
Gambarota, Giulio
Whitcher, Brandon
Allen, Clare
Kirkham, Alex
Emberton, Mark

January 2017

International audiencePURPOSE: Dutasteride, which is licensed for symptomatic benign prostatic hyper...

Dutasteride and prostate cancer.

Kiemeney, L.A.L.M.
Bosland, M.C.

January 2010

Contains fulltext : 88812.pdf (publisher's version ) (Open Access

Words of wisdom. Re: effect of dutasteride on the risk of prostate cancer.

Bosland, M.C.
Cremers, R.G.H.M.
Kiemeney, L.A.L.M.

January 2010

Contains fulltext : 87442.pdf (publisher's version ) (Closed access)1 oktober 201

Correspondence to

Andrew Vickers

September 2016

Dutasteride reduces incident prostate cancer in men after negative prostate biops

The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED—A Randomized, Placebo Controlled, Double-Blind Clinical Trial

Moore, C.M.
Robertson, N.L.
Jichi, F.
Damola, A.
Ambler, G.
Giganti, F.
Ridout, A.J.
Bott, S.R.J.
Winkler, M.
Ahmed, H.U.
Arya, M.
Mitra, A.V.
McCartan, N.
Freeman, A.
Jameson, C.
Castro, R.
Gambarota, G.
Whitcher, B.
Allen, C.
Kirkham, A.
Emberton, M.
Moore, C.M.
Robertson, N.L.
Jichi, F.
Damola, A.
Ambler, G.
Giganti, F.
Ridout, A.J.
Bott, S.R.J.
Winkler, M.
Ahmed, H.U.
Arya, M.
Mitra, A.V.
McCartan, N.
Freeman, A.
Jameson, C.
Castro, R.
Gambarota, G.
Whitcher, B.
Allen, C.
Kirkham, A.
Emberton, M.

January 2017

Purpose: Dutasteride, which is licensed for symptomatic benign prostatic hyperplasia, has been assoc...

MAPPED study design: A 6month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging

Robertson, N.L.
Moore, C.M.
Ambler, G.
Bott, S.R.J.
Freeman, A.
Gambarota, G.
Jameson, C.
Mitra, A.V.
Whitcher, B.
Winkler, M.
Kirkham, A.
Allen, C.
Emberton, M.
Robertson, N.L.
Moore, C.M.
Ambler, G.
Bott, S.R.J.
Freeman, A.
Gambarota, G.
Jameson, C.
Mitra, A.V.
Whitcher, B.
Winkler, M.
Kirkham, A.
Allen, C.
Emberton, M.

January 2013

Objective To evaluate the percentage change in volume of prostate cancer, as assessed by T2-weighted...

Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial

Milonas, Daimantas
Auskalnis, Stasys
Skulcius, Giedrius
Gudinaviciene, Inga
Jievaltas, Mindaugas
Joniau, Steven

May 2017

High-grade prostatic intraepithelial neoplasia (HGPIN) is a potential precursor of prostate cancer (...

MAPPED study design: A 6 month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging

Robertson, N. L.
Moore, C. M.
Ambler, G.
Bott, S. R. J.
Freeman, A.
Gambarota, Giulio
Jameson, C.
Mitra, A. V.
Whitcher, B.
Winkler, M.
Kirkham, A.
Allen, C.
Emberton, M.

January 2013

International audienceOBJECTIVE: To evaluate the percentage change in volume of prostate cancer, as ...

Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: a randomized, open-label, parallel-group pilot study.

Gils, M.P.M.Q.
Hessels, D.
Peelen, W.P.
Vergunst, H.
Mulders, P.F.A.
Schalken, J.A.

January 2009

Contains fulltext : 81903schalken.pdf (publisher's version ) (Closed access)BACKGR...

The effect of dutasteride on microscopic and macroscopic changes of testosterone replacement treatment on prostate tissue

Diri, Mehmet Akif
Diri, Banu
Yıldız, Levent
Büyükalpelli, Recep

January 2018

WOS: 000451785300010PubMed: 30024036Testosterone replacement therapy has a growing interest in daily...

Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study

Schroeder, Fritz H.
Bangma, Chris H.
Wolff, Johannes M.
Alcaraz, Antonio
Montorsi, Francesco
Mongiat-Artus, Pierre
Abrahamsson, Per-Anders
McNicholas, Tom A.
Castro, Ramiro S.
Nandy, Indrani M.

January 2009

To describe the Avodart after Radical Therapy for prostate cancer Study (ARTS), investigating the us...

Steroid Hormone Receptors As Potential Mediators Of The Clinical Effects Of Dutasteride: A Prospective, Randomized, Double-blind Study

Alonso
Joao C. C.
Leonardo O.
Patrick V.
Ubirajara
Wagner E.
Fabiano A.
Ronald F.
Maria Isabel C.
Wagner J.

November 2017

This study characterizes the clinical and morphofunctional effects of a 5 alpha-reductase inhibitor ...

Effect of dutasteride on the risk of prostate cancer.

Andriole, G.L.
Bostwick, D.G.
Brawley, O.W.
Gomella, L.G.
Marberger, M.
Montorsi, F.
Pettaway, C.A.
Tammela, T.L.J.
Teloken, C.
Tindall, D.J.
Somerville, M.C.
Wilson, T.H.
Fowler, I.L.
Rittmaster, R.S.
Mulders, P.F.A.
Schrier, B.P.
et al.

January 2010

BACKGROUND: We conducted a study to determine whether dutasteride reduces the risk of incident prost...

Effect of Dutasteride on the Risk of Prostate Cancer

Donald J. Tindall
Ivy L. Fowler
Roger S. Rittmaster
N Engl
J Med

December 2014

*The principal investigators in the Reduc-tion by Dutasteride of Prostate Cancer Events (REDUCE) stu...

The effect of dutasteride on magnetic resonance imaging defined prostate cancer: MAPPED-a randomized, placebo controlled, double-blind clinical trial

Moore, CM
Robertson, NL
Jichi, F
Damola, A
Ambler, G
Giganti, F
Ridout, AJ
Bott, SRJ
Winkler, M
Ahmed, HU
Arya, M
Mitra, AV
McCartan, N
Freeman, A
Jameson, C
Castro, R
Gambarota, G
Whitcher, BJ
Allen, C
Kirkham, A
Emberton, M

November 2016

Purpose Dutasteride, which is licensed for symptomatic benign prostatic hyperplasia, has been associ...

The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical Trial

Moore, Caroline M.
Robertson, Nicola L.
Jichi, Fatima
Damola, Adebiyi
Ambler, Gareth
Giganti, Francesco
Ridout, Ashley J.
Bott, Simon R. J.
Winkler, Mathias
Ahmed, Hashim U.
Arya, Manit
Mitra, Anita V.
McCartan, Neil
Freeman, Alex
Jameson, Charles
Castro, Ramiro
Gambarota, Giulio
Whitcher, Brandon
Allen, Clare
Kirkham, Alex
Emberton, Mark

January 2017

International audiencePURPOSE: Dutasteride, which is licensed for symptomatic benign prostatic hyper...

Dutasteride and prostate cancer.

Kiemeney, L.A.L.M.
Bosland, M.C.

January 2010

Contains fulltext : 88812.pdf (publisher's version ) (Open Access

Words of wisdom. Re: effect of dutasteride on the risk of prostate cancer.

Bosland, M.C.
Cremers, R.G.H.M.
Kiemeney, L.A.L.M.

January 2010

Contains fulltext : 87442.pdf (publisher's version ) (Closed access)1 oktober 201

Correspondence to

Andrew Vickers

September 2016

Dutasteride reduces incident prostate cancer in men after negative prostate biops

The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED—A Randomized, Placebo Controlled, Double-Blind Clinical Trial

Moore, C.M.
Robertson, N.L.
Jichi, F.
Damola, A.
Ambler, G.
Giganti, F.
Ridout, A.J.
Bott, S.R.J.
Winkler, M.
Ahmed, H.U.
Arya, M.
Mitra, A.V.
McCartan, N.
Freeman, A.
Jameson, C.
Castro, R.
Gambarota, G.
Whitcher, B.
Allen, C.
Kirkham, A.
Emberton, M.
Moore, C.M.
Robertson, N.L.
Jichi, F.
Damola, A.
Ambler, G.
Giganti, F.
Ridout, A.J.
Bott, S.R.J.
Winkler, M.
Ahmed, H.U.
Arya, M.
Mitra, A.V.
McCartan, N.
Freeman, A.
Jameson, C.
Castro, R.
Gambarota, G.
Whitcher, B.
Allen, C.
Kirkham, A.
Emberton, M.

January 2017

Purpose: Dutasteride, which is licensed for symptomatic benign prostatic hyperplasia, has been assoc...

MAPPED study design: A 6month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging

Robertson, N.L.
Moore, C.M.
Ambler, G.
Bott, S.R.J.
Freeman, A.
Gambarota, G.
Jameson, C.
Mitra, A.V.
Whitcher, B.
Winkler, M.
Kirkham, A.
Allen, C.
Emberton, M.
Robertson, N.L.
Moore, C.M.
Ambler, G.
Bott, S.R.J.
Freeman, A.
Gambarota, G.
Jameson, C.
Mitra, A.V.
Whitcher, B.
Winkler, M.
Kirkham, A.
Allen, C.
Emberton, M.

January 2013

Objective To evaluate the percentage change in volume of prostate cancer, as assessed by T2-weighted...

Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial

Milonas, Daimantas
Auskalnis, Stasys
Skulcius, Giedrius
Gudinaviciene, Inga
Jievaltas, Mindaugas
Joniau, Steven

May 2017

High-grade prostatic intraepithelial neoplasia (HGPIN) is a potential precursor of prostate cancer (...

MAPPED study design: A 6 month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging

Robertson, N. L.
Moore, C. M.
Ambler, G.
Bott, S. R. J.
Freeman, A.
Gambarota, Giulio
Jameson, C.
Mitra, A. V.
Whitcher, B.
Winkler, M.
Kirkham, A.
Allen, C.
Emberton, M.

January 2013

International audienceOBJECTIVE: To evaluate the percentage change in volume of prostate cancer, as ...

Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: a randomized, open-label, parallel-group pilot study.

Gils, M.P.M.Q.
Hessels, D.
Peelen, W.P.
Vergunst, H.
Mulders, P.F.A.
Schalken, J.A.

January 2009

Contains fulltext : 81903schalken.pdf (publisher's version ) (Closed access)BACKGR...

The effect of dutasteride on microscopic and macroscopic changes of testosterone replacement treatment on prostate tissue

Diri, Mehmet Akif
Diri, Banu
Yıldız, Levent
Büyükalpelli, Recep

January 2018

WOS: 000451785300010PubMed: 30024036Testosterone replacement therapy has a growing interest in daily...

Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study

Schroeder, Fritz H.
Bangma, Chris H.
Wolff, Johannes M.
Alcaraz, Antonio
Montorsi, Francesco
Mongiat-Artus, Pierre
Abrahamsson, Per-Anders
McNicholas, Tom A.
Castro, Ramiro S.
Nandy, Indrani M.

January 2009

To describe the Avodart after Radical Therapy for prostate cancer Study (ARTS), investigating the us...

Steroid Hormone Receptors As Potential Mediators Of The Clinical Effects Of Dutasteride: A Prospective, Randomized, Double-blind Study

Alonso
Joao C. C.
Leonardo O.
Patrick V.
Ubirajara
Wagner E.
Fabiano A.
Ronald F.
Maria Isabel C.
Wagner J.

November 2017

This study characterizes the clinical and morphofunctional effects of a 5 alpha-reductase inhibitor ...

Effect of dutasteride on the risk of prostate cancer.

Abstract

Extracted data

Effect of dutasteride on the risk of prostate cancer.

Abstract

Extracted data

Related items

Related items